Compare

Drugs Made In America Acquisition Corp. vs Fifth Era Acquisition Corp I vs Archimedes Tech SPAC Partners II Co. vs Roman DBDR Acquisition Corp. II

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Drugs Made In America Acquisition Corp. DMAA	Fifth Era Acquisition Corp I FERA	Archimedes Tech SPAC Partners II Co. ATII	Roman DBDR Acquisition Corp. II DRDB
Year ended	2025-12-31	2025-12-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	$5.94M	$4.13M	$7.99M	$7.74M
EPS (Diluted)	n/a	n/a	n/a	n/a
Operating cash flow	-$539.2K	-$890.6K	-$739.0K	-$1.29M
Free cash flow	n/a	n/a	n/a	n/a
Cash & equivalents	n/a	$543.3K	$1.36M	$183.0K
Total assets	$239.92M	$238.58M	$241.35M	$241.51M
Total liabilities	$7.28M	$14.06M	$8.19M	$1.10M
Shareholders' equity	-$7.26M	-$13.33M	-$6.70M	-$778.1K
Return on year-end equity	n/a	n/a	n/a	n/a
Shares outstanding	10.72M	n/a	6.59M	n/a

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Drugs Made In America Acquisition Corp.	Fifth Era Acquisition Corp I	Archimedes Tech SPAC Partners II Co.	Roman DBDR Acquisition Corp. II
Latest	n/a	n/a	n/a	n/a
1 year earlier	n/a	n/a	n/a	n/a
2 years earlier	n/a	n/a	n/a	n/a
3 years earlier	n/a	n/a	n/a	n/a
4 years earlier	n/a	n/a	n/a	n/a